Почетна › Akutna mijeloidna leukemija › Северна Каролина › Charlotte
Kliničke studije za Akutna mijeloidna leukemija u gradu Charlotte, NC
18 studija za Akutna mijeloidna leukemija traži učesnike na lokacijama u gradu Charlotte i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Тражи се учесникФаза 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Тражи се учесникФаза 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Тражи се учесникФаза 3
- US-Charlotte NC-NOVANTCHARLOTTE, Charlotte
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Тражи се учесникФаза 3
- Atrium Health, Charlotte
- Novant Health Charlotte, Charlotte
- Carolina Oncology Specialists, Charlotte
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Тражи се учесникФаза 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
Тражи се учесникОпсервациона студија
- Novant Health Cancer Institute, Charlotte
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Тражи се учесникФаза 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Тражи се учесникФаза 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Тражи се учесникОпсервациона студија
- Novant Health Weisiger Cancer Institute, Charlotte
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Тражи се учесникФаза 3
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Тражи се учесникФаза 2
- Novant Health Clinical Research, Charlotte
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Тражи се учесникФаза 1/2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Тражи се учесникФаза 1
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Тражи се учесникФаза 1
- Atrium Health Levine Cancer Center, Charlotte
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
Тражи се учесникОпсервациона студија
- Levine Cancer Institute, Charlotte
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
Тражи се учесник
- Levine Cancer Insitute, Charlotte
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Тражи се учесникОпсервациона студија
- Levine Children's Hospital, Charlotte
Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
Тражи се учесникФаза 1/2
- Novant Health Cancer Institute, Charlotte
Studije za Akutna mijeloidna leukemija u drugim gradovima
- Houston, TX88 студија
- New York City, NY51 студија
- Boston, MA44 студија
- Baldwin Park, CA41 студија
- Seattle, WA40 студија
- Durham, NC34 студија
- Columbus, OH34 студија
- Philadelphia, PA33 студија
- Atlanta, GA30 студија
- Tampa, FL30 студија
- Chicago, IL27 студија
- Los Angeles, CA25 студија
Ostale studije u gradu Charlotte
- Рак (све врсте)29 студија
- Рак дојке22 студија
- Немалоклетни карцином плућа22 студија
- Многи мијелом21 студија
- Рак јајника16 студија
- Гојазност16 студија
- Колоректални карцином15 студија
- Гојазност15 студија
- Метастатски карцином12 студија
- Затајење срца12 студија
- Плоскоклеточни карцином главе и врата11 студија
- ХОБП10 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.